About Dana Barnard
Dana Barnard co-founded Mercury Bio with Bruce McCormick. He chairs its board. The company develops medicines that enter cells affected by Parkinson’s and Alzheimer’s disease. Barnard also serves as chief executive of Barson, Himed and Big Giant Donut. Barson invests in and advises early-stage ventures. Himed supplies calcium phosphate biomaterials and provides surface treatments.
He moved to Houston and ran a family-business division supplying engineered surfaces to oil, gas and petrochemical companies. Its work supported the Space Shuttle Solid Rocket Motors, Titan and Pegasus programs. At Barson, he served as chief financial officer before becoming chief executive. He expanded Barson’s aerospace-coatings and bioceramics businesses. He also invested in and helped grow SAVSU Technologies, which was later sold to BioLife Solutions. After Barson sold Hitemco, Barnard helped start and invest in Mercury Bio and Frame Bio. He earned a Kellogg MBA at Northwestern, focusing on finance and strategy.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Dana Barnard in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dana Barnard works with at each company, as listed on that company's latest Form D.